Does treatment of acute herpes zoster prevent or shorten postherpetic neuralgia? A systematic review of the literature

Journal of Family Practice

Volumn 49, Issue 3, 2000, Pages 255-264

  Alper, Brian S ^a   Lewis, Peter R ^a  

^a NONE

Author keywords

Aged; Herpes zoster; Neuralgia; Postherpetic non MESH

Indexed keywords

ACICLOVIR; AMITRIPTYLINE; ANTIVIRUS AGENT; CORTICOTROPIN; FAMCICLOVIR; PREDNISOLONE; STEROID; TRIAMCINOLONE; TRICYCLIC ANTIDEPRESSANT AGENT; VALACICLOVIR;

ADULT; AGED; CLINICAL TRIAL; DISEASE DURATION; DRUG EFFICACY; ELECTROSTIMULATION; HERPES ZOSTER; HUMAN; INCIDENCE; META ANALYSIS; NERVE STIMULATION; PAIN; POSTHERPETIC NEURALGIA; REVIEW;

ACUTE DISEASE; ACYCLOVIR; AGED; AMITRIPTYLINE; ANALGESICS, NON-NARCOTIC; ANTIVIRAL AGENTS; DRUG THERAPY, COMBINATION; EVIDENCE-BASED MEDICINE; HERPES ZOSTER; HUMANS; MIDDLE AGED; NEURALGIA; RANDOMIZED CONTROLLED TRIALS; STEROIDS;

EID: 0033912035     PISSN: 00943509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (53)

1. Helgason S, Sigurdsson JA, Gudmundsson S. The clinical course of herpes zoster: a prospective study in primary care. Eur J Gen Pract 1996; 2:12-6.
2. Burgoon CF, Burgoon JS, Baldridge GD. The natural history of herpes zoster. JAMA 1957; 164:265-9.
3. Volmink J, Lancaster T, Gray S, Silagy C. Treatments for postherpetic neuralgia - a systematic review of randomized controlled trials. Fam Pract 1996; 13:84-9.
4. Lancaster T, Silagy C, Gray S. Primary care management of acute herpes zoster: systematic review of evidence from randomized controlled trials. Br J Gen Pract 1995; 45:39-45.
5. Schmader KE, Studenski S. Are current therapies useful for the prevention of postherpetic neuralgia? A critical analysis of the literature. J Gen Intern Med 1989; 4:83-9.
6. Tyring S, Barbarash RA, Nahlik JE, et al. Famciclovir for the treatment of acute herpes zoster effects on acute disease and postherpetic neuralgia. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 1995; 123:89-96.
7. Bentner KR, Friedman DJ, Forszpaniak C, Andersen PL, Wood MJ. Valacyclovir compared with acyclovir for improved therapy for herpes zoster in immunocompetent adults. Antimicrob Agents Chemother 1995; 39:1546-53.
8. Bowsher D. The effects of preemptive treatment of postherpetic neuralgia with amitriptyline: a randomized, double blind, placebo-conlrolled trial. J Pain Symptom Manage 1997; 13:327-31.
9. Rowbotham M, Harden N, Stacey B, Bernstein P, Magnus-Miller L. Gabapentin for the treatment of postherpetic neuralgia: a randomized controlled trial. JAMA 1998; 280:1837-42.
10. Lycka BAS. Postherpetic neuralgia and systemic corticosteroid therapy: efficacy and safety. Int J Dermatol 1990; 29:523-7.
11. Post BT, Philbrick JT. Do corticosteroids prevent postherpetic neuralgia? A review of the evidence. J Am Acad Dermatol 1988; 18:605-10.
12. Dwyer DE. Management issues in herpes zoster. Aust Fam Physician 1996; 25:299-307.
13. Wood MJ. How should we measure pain in herpes zoster? Neurology 1995; 45(suppl):S61-2.
14. Emerson JD, Burdick E, Hoaglin DC, Mosteller, F, Chalmers TC. An empirical study of the possible relation of treatment differences to quality scores in controlled randomized clinical trials. Control Clin Trials 1990; 11:339-52.
15. Mulrow CD, Oxman AD, eds. "Quality" scales and checklists. Cochrane Collaboration handbook, section 6.7.2. In: The Cochrane library. The Cochrane Collaboration. Oxford, England: Update Software; 1997, issue 1.
16. Wood MJ, Ogan PH, McKendrick MW, Care CD, McGill JI, Webb EM. Efficacy of oral acyclovir treatment of acute herpes zoster. Am J Med 1988; 85:79-83.
17. Cobo LM, Foulks GN, Liesegang T, et al. Oral acyclovir in the treatment of acute herpes zoster ophthalmicus. Ophthalmology 1986; 93:763-70.
18. McKendrick MW, McGill JI, Wood MJ. Lack of effect of acyclovir on postherpetic neuralgia. BMJ 1989; 289;131.
19. McKendrick MW, McGill JI, White JE, Wood MJ. Oral acyclovir in acute herpes zoster. BMJ 1986; 293:1529-32.
20. Wood MJ, McKendrick MW, McGill JI. Oral acyclovir for acute herpes zoster infections in immune-competent adults. Infection 1987; 15(suppl):S9-13.
21. McGill JI, White JE. Acyclovir and post-herpetic neuralgia and ocular involvement. BMJ 1994; 309:1124.
22. McKendrick MW, Wood MJ. Acyclovir and post-herpetic neuralgia; two other participating study enters report different results. BMJ 1995; 310:1005.
23. Crooks RJ, Jones DA, Fiddian AP. Zoster-associated chronic pain: an overview of clinical trials with acyclovir. Stand J Infect Dis 1991; 78(suppl);62-8.
24. Wood MJ, Kay R, Dworkin RH, Soong SJ, Whaley RJ. Oral acyclovir therapy accelerates pain resolution in patients with herpes zoster: a meta-analysis of placebo-controlled trials. Clin Infect Dis 1996; 22:341-7.
25. Huff JC, Bean B, Balfour HH, et al. Therapy of herpes zoster with oral acyclovir. Am J Med 1988; 85:84-9.
26. Huff JC. Oral acyclovir therapy of acute herpes zoster: a multicentre study. Res Clin Forums 1987; 9:37-45.
27. Huff JC, Drucker JL, Clemmer A, Laskin OL, Connor JD, Bryson YJ, et al. Effect of oral acyclovir on pain resolution in herpes zoster: a reanalysis. J Med Virol 1993;Suppl 1:93-6.
28. Morton P, Thomson AN. Oral acyclovir in the treatment of herpes zoster in general practice. N Z Med J 1989; 102:93-5.
29. Harding SP, Porter SM. Oral acyclovir in herpes zoster ophthalmicus. Curr Eye Res 1991: 10(suppl):177-82.
30. Jackson JL, Gibbons R, Meyer G, Inouye L. The effect of treating herpes zoster with oral acyclovir in preventing postherpetic neuralgia: a meta-analysis. Arch Intern Med 1997; 157:909-12.
31. Whitley RJ, Weiss H, Gnann JW, et al. Acyclovir with and without prednisone for the treatment of herpes zoster: a randomized, placebo-controlled trial. Ann Intern Med 1996; 1996; 125:376-83.
32. The Cochrane Collaboration. The database of abstracts of review of effectiveness. DARE-978103. In: The Cochrane library. Oxford, England: Update Software; 1998, issue 4.
33. Hoang-Xuan T, Buchi EB, Herbort CP, et al. Oral acyclovir for herpes zosier ophthalmicus. Ophthalmology 1992: 99:1062-71.
34. - days or 21 days with and without prednisolone for treatment of acute herpes zoster. N Engl J Med 1994; 330:896-900.
35. Wassilew SW, Reimlinger S, Nasemann T, Jones D. Oral acyclovir for herpes zoster: a double-blind controlled trial in normal subjects. Br J Dermatol 1987; 117:495-501.
36. McKendrick MW, Care C, Burke C, Hickmott E, McKendrick GDW. Oral acyclovir in herpes zoster. J Antimicrob Chemother 1984; 14:661-5.
37. Dworkin RH, Boon RJ, Griffin DRG, Phung D. Postherpetic neuralgia: impact of famciclovir, age, rash severity, and acute pain in herpes zoster patients. J Infect Dis 1998; 178(suppl); S76-80.
38. Watson CP, Deck JH, Morshead C, Van der Kooy D, Evans RJ. Post-herpetic neuralgia: further post-mortem studies of cases with and without pain. Pain 1991; 44:105-17.
39. Esmann V, Kroon S, Peterslund NA, et al. Prednisolnne does not prevent post-herpetic neuralgia. Lancet 1987; 2:126-9.
40. Clemmensen OJ, Andersen KE. ACTH versus prednisone and placebo in herpes zoster treatment. Clin Exp Dermatol 1984; 9:557-63.
41. Keczkes K, Basheer AM. Do corticosteroids prevent post-herpetic neuralgia? Br J Dermatol 1980; 102:551-5.
42. Eaglstein WH, Katz R, Brown JA. The effects of early corticosteroid therapy on the eruption and pain of herpes zoster. JAMA 1970; 211-1681-3.
43. Herbert DA, Carson MP. Acyclovir plus steroids for herpes zoster. Ann Intern Med 1997; 126:831-2.
44. MacFarlane LL, Simmons MM, Hunter MH. The use of corticosteroids in the management of herpes zosier. J Am Board Fam Pract 1998; 11:224-8.
45. Max MB, Culnane M, Schafer SC, et al. Amitriptyline relieves diabetic neuropathy pain in patients with normal or depressed mood. Neurology 1987; 37:589-96.
46. Ahmed HE, Craig WF, White PF, et al. Percutaneous electrical nerve stimulation: an alternative to antiviral drugs for acute herpes zoster. Anesth Analg 1998; 87:911-4.
47. Wood MJ, Balfour H, Beutner K, et al. How should zoster trials be conducted? J Antimicrob Chemother 1995; 36:1089-101.
48. Dworkin RH, Portenoy RK. Proposed classification of herpes zoster pain. Lancet 1994; 343:1648.
49. van den Broek PJ, Stuyt PM, van der Meer JW. Acyclovir for herpes zoster. N Engl J Med 1994; 331:481.
50. Gershon A. Varicella: to vaccinate or not to vaccinate? Arch Dis in Childhood 1998; 79:470-4.
51. Oxman MN. Imnumization to reduce the frequency and severity of herpes zoster and its complications. Neurology 1995; 45(suppl):S11-6.
52. Stephenson J. Shingles vaccine trial in health agencies update. JAMA 1999; 282:625. Available on the World Wide Web at http://jama.ama-assn.org/issues/v282p7/full/jha90006-4.html.
53. Garnett GP, Grenfell BT. The epidemiology of varicella-zoster virus infections: the influence of varicella on the prevalence of herpes zoster. Epidemiol Infect 1992; 108:513-28.